The active management of depression

Journal of Family Practice

Volumn 51, Issue 9, 2002, Pages 769-776

  Culpepper, Larry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CYTOCHROME P450; ESCITALOPRAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGITATION; ANXIETY; DEPRESSION; DRUG DEPENDENCE; EARLY DIAGNOSIS; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; NEUROTOXICITY; PATIENT COUNSELING; PATIENT EDUCATION; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; REMISSION; REVIEW; SEXUAL DYSFUNCTION; SLEEP DISORDER; TREMOR; UNITED STATES; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; FAMILY PRACTICE; HUMANS; PATIENT EDUCATION; QUESTIONNAIRES;

EID: 0036713042     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. The quality of care for depressive and anxiety disorders in the United States
2. Committee on Health and Behavior: Research practice and policy
3. The course of major depression in diabetes
4. Mental health care in the primary care setting
5. Somatic presentation of DSM III psychiatric disorders in primary care
6. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care
7. Case-finding instruments for depression: Two questions are as good as many
8. The PHQ-9: Validity of a brief depression severity measure
9. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire
10. Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders
11. Validity of the Zung Self-rating Depression Scale
12. The validity of two versions of the GHQ in the WHO study of mental illness in general health care
13. Postpartum depressive disorders
14. Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal variables
15. Onset and persistence of postpartum depression in an innercity maternal health clinic system
16. Routine screening for postpartum depression
17. Review of validation studies of the Edinburgh Postnatal Depression Scale
18. The natural history and heterogeneity of depressive disorders: Implications for rational antidepressant therapy
19. Anxiety symptom relief in depression treatment outcomes
20. Antidepressant or antianxiety? A study of the efficacy of antidepressant medication
21. Recognition and assessment of sexual dysfunction associated with depression
22. Sexual dysfunction before antidepressant therapy in major depression
23. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial
24. Dispelling the myths and stigma of mental illness: The Surgeon General's report on mental health
25. The role of the primary care physician in patients' adherence to antidepressant therapy
26. Stimulus control instructions
27. Worries and anxiety
28. Exercise as an effective treatment option for major depression in older adults
29. Primary care physician use of cognitive behavioral techniques with depressed patients
30. Psychotherapies for depressive disorders: A review
31. Selection of an antidepressant: Mirtazapine
32. SSRIs versus other antidepressants for depressive disorder
33. Debate resolved: There are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymes
34. Antidepressant options in primary care
35. Drug interactions with newer antidepressants: Role of human cytochromes P450
36. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism
37. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment
38. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
39. Sexual functioning and SSRIs
40. Strategies for the treatment of antidepressant-related sexual dysfunction
41. What are the treatment options for SSRI-related sexual dysfunction?
42. Sildenafil for women patients with antidepressant-induced sexual dysfunction
43. Escitalopram 10mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
44. Compliance and therapeutic issues in resistant depression
45. Treatment-resistant depression
46. What role do atypical antipsychotic drugs have in treatment-resistant depression?
47. Practice guideline for the treatment of patients with major depressive disorder (revision)
48. What to do with SSRI nonresponders?
49. Management of treatment-resistant depression: Psychotherapeutic perspectives
50. Augmentation and combination strategies in treatment-resistant depression
51. Treating antidepressant nonresponders with augmentation strategies: An overview
52. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence
53. The long-term treatment of depression
54. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program
55. Prevention of recurrent postpartum major depression
56. Treating major depression in primary care practice: An update of the Agency for Health Care Policy and Research Practice Guidelines
57. Treating depression in primary care practice: Applications of research findings
58. Collaborative management to achieve treatment guidelines. Impact on depression in primary care
59. A multifaceted intervention to improve treatment of depression in primary care
60. Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial
61. Improving depression care: Barriers, solutions, and research needs
62. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care